Currently we test and support the following browsers:
It varies. Outcomes for children undergoing autologous or allogeneic hematopoietic stem cell / bone marrow transplant have improved during the past several decades. However, outcomes vary according to the patient’s underlying disease and the patient’s disease status at the time of transplantation. For example, clinical trials at St. Jude have shown that patients who have hematologic malignancies and receive grafts from matched siblings have outcomes similar to those of patients who have the same diseases but receive grafts from unrelated donors. Your transplant physician can discuss this question with you once he or she has reviewed your child’s treatment, disease status, selection of stem cell collection, and pre-evaluation results.
Last update: October 2003